Related Experiment Videos
[Essential arterial hypertension. A therapeutic proposal].
Archivio Per Le Scienze Mediche
|July 1, 1981
Summary
Aldatense effectively lowers blood pressure over 120 days in essential hypertension patients. This long-term treatment shows a good therapeutic index with minimal side effects and no impact on key metabolic functions.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Essential hypertension is a widespread cardiovascular condition requiring effective long-term management.
- Evaluating novel therapeutic agents for hypertension is crucial for improving patient outcomes.
Purpose:
- To assess the therapeutic efficacy and tolerance of Aldatense in patients with essential hypertension over a 120-day treatment period.
Summary:
- Aldatense demonstrated a potent, gradual, and progressively stable antihypertensive effect in 77 patients.
- Personalized posology (1-2 tablets/day) was adjusted based on therapeutic response.
- The drug exhibited a favorable therapeutic index with a low incidence of side effects.
Impact:
- Aldatense did not adversely affect blood potassium levels, carbohydrate and purine metabolism, or renal function.
- The findings support Aldatense as a safe and effective option for managing essential hypertension.
- This study contributes valuable data on the long-term safety and efficacy profile of Aldatense.